July 9, 2007—Jacobs Engineering Group Inc. has announced that it is providing engineering, procurement, and construction management services for a new Novartis manufacturing facility to be located in Holly Springs, N.C. Officials did not disclose the contract value.
The new facility will produce trivalent pandemic and interpandemic influenza vaccines utilizing an innovative cell culture based process for US and overseas markets. Jacobs is providing services on-site and from its Cincinnati office.
Jacobs, with over 46,000 employees and revenues exceeding $8 billion, provides technical, professional, and construction services globally. For more information, see the Web site.
